Divis Lab gets 5 observations from USFDA for Vizag plant
Drug firm Divis Laboratories on Wednesday said US health regulator has made five observations after inspection of its manufacturing plant at Visakhapatnam in Andhra Pradesh.

In a regulatory filing, the company said Unit-II at Visakhapatnam, Andhra Pradesh has had an inspection by the US Food and Drug Administration (USFDA) from November 29 to December 6....

http://health.economictimes.indiatimes.com/news/pharma/divis-lab-gets-5-observations-from-usfda-for-vizag-plant/55865822
Like
Comment
Share